Access Digital Health
CountriesInterventionsToolsAbout
Log in
← Interventions

HPV vaccination (2 doses) for preventing cervical cancer

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
$55–209
WHO-CHOICE modeled
GiveWell
—
no GiveWell model
CE sources
3
Tier A · 457 studies
Source agreement
2.6×
sources contradict
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

Modeled benchmarks ($/DALY)Tier A · standardized benchmark
South-East Asia$209.00View source →
Eastern sub-Saharan Africa$55.00View source →

WHO-CHOICE estimates are modeled at population-level population coverage, compared against the null set (no intervention) under generalized cost-effectiveness analysis. View WHO-CHOICE methodology →

$/DALY sources differ by 3.8x - a material difference.

Modeled regional estimates — not realized delivery costs.

Published study estimates ($/DALY)Tier B · context only

Tufts GHCEA · 454 studies, varied methods — explore the spread, not a single number.

Health-system
$523
median · n=357
Mixed
$180
median · n=65
Societal
$220
median · n=32
Filter the cohort
$382median of 454 studies · IQR $100–$1,575 · 10 cost-saving
Published study estimates ($/DALY)Tier B · context only
DCP3 (2013 reference)$50median · 3 studies

range $50–$240/DALY. Varied methods — not directly comparable.

Tier-A sources diverge 3× — WHO-CHOICE $132 vs dcp3_extract $50. Shown side by side, never merged into one figure.
Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is not currently shown. The country health-system view — workforce density, financing mix, service coverage — is being rebuilt as part of the scenario layer. The underlying indicators remain in the country pages.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for HPV vaccination (2 doses) for preventing cervical cancer? Select a country above, then open its intelligence page.